An interventional study of FT254421 and FT25631 in Smoking and Tobacco, sponsored by RAI Services Company. Recruiting at 3 sites in United States. Open to participants aged 21 Years to 65 Years, including healthy volunteers. Per ClinicalTrials.gov, last updated 2026-11-16.
Sponsored by RAI Services Company (part of British American Tobacco) · Not applicable, Interventional, and Other
Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →
Among 55 studies in Smoking by British American Tobacco — 12 open to participants now, 12 under way, none of them phase 3. Smoking · British American Tobacco.
Among the 55 studies in Smoking by British American Tobacco, this one is the 10th largest by planned enrollment of the 52 interventional ones that give a count, is one of 11 that started in 2026, is one of 52 with no phase, reaches primary completion later than 10 of the 11 other live ones, and was the 55th registered.
1,513 studies on the registry are indexed under Smoking; 194 are open to participants now.
Browse Smoking studies →12 of the 55 studies in Smoking by British American Tobacco are open now, in 1 country. Recruiting first, the newest first:
RAI Services Company · Sites in United States
Ages 21–65 · Healthy volunteers
RAI Services Company · Sites in United States
Ages 21–65 · Healthy volunteers
RAI Services Company · Sites in United States
Ages 21–65 · Healthy volunteers
RAI Services Company · Sites in United States
Ages 21–60 · Healthy volunteers
RAI Services Company
Ages 21–60 · Healthy volunteers
By country, each count listing its studies:
Of the 140 Smoking studies recruiting now, 74 (53%) set no upper age limit and 48 (34%) stop at 75 or younger; 3 take children under 18; 65 take healthy volunteers.
This study: 21 Years to 65 Years · all sexes · healthy volunteers too.
The full table on the hub →This tab as a report to print or save as PDF → With an account.
55 studies; the count open now beside each. This study's row is marked.
First in 2007; this study’s year is marked. 11 started in 2026.
This study's planned enrollment of 200 is above the median of 115 across 1,165 interventional studies indexed under Smoking.
Median enrollment 70 across the 52 interventional studies, 1,105 across the 3 observational. Of the 43 that completed or were terminated, 0 (0%) have results posted.
This tab as a report to print or save as PDF → With an account.
This study is registered under RAI Services Company, one of the names counted as British American Tobacco. Under that name alone:
RAI Services Company is the lead sponsor of 54 studies on the registry; 13 are open to participants now.
6 of the studies in Smoking by British American Tobacco that are under way reach primary completion within a year, 0 of them phase 3. Phase 3 first, then by date:
| Study | Primary completion |
|---|---|
| NCT07881848RAI Services CompanyA Study to Assess Nicotine Uptake From a Menthol Electronic Nicotine Delivery System Product | 2026-12 |
| NCT07739797RAI Services CompanyA Study to Assess Nicotine Uptake From Electronic Nicotine Delivery System Products | 2026-12 |
| NCT07710820RAI Services CompanyA Multi-Site Study to Assess the Effect of Availability of a Heated Tobacco Product on Smoking Abstinence Among Current Primary Cigarette Smokers | 2026-12 |
| NCT07598136RAI Services CompanyA Study to Determine the Effects of ENDS Flavor Availability on Abstinence Within Smokers | 2026-12-17 |
| NCT07938320RAI Services CompanyVuse Pro Puffing Topography Study in Adult Smokers | 2027-01 |
Add all 6 to your calendar (.ics) → With an account.
Among the 55 studies in Smoking by British American Tobacco, from their registry updates:
This tab as a report to print or save as PDF → With an account.
This is a multi-site, open-label, randomized study to measure puffing topography of generally healthy adult smokers of cigarettes when provided with an electronic nicotine delivery system over a 14-day period of product use.
This will be a multi-site, open-label, parallel design, four-arm, randomized cohort study to measure the puffing topography of generally healthy adult smokers of combustible cigarettes (CCs) when provided with an electronic nicotine delivery system (ENDS) over a 14-day product use period.
Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.
Exclusion Criteria:
Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorized to decide for you.
You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.
Ways of preventing pregnancy. “Highly effective” methods fail less than 1% of the time a year when used correctly — for example an IUD or an implant.
Criteria usually say which methods count and how long to keep using them after the last dose, sometimes for male participants too. Some studies accept a partner’s vasectomy if it was confirmed successful and that person is the participant’s only sexual partner.
Informed consent
Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorized to decide for you.
You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.
Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
Contraception
Ways of preventing pregnancy. “Highly effective” methods fail less than 1% of the time a year when used correctly — for example an IUD or an implant.
Criteria usually say which methods count and how long to keep using them after the last dose, sometimes for male participants too. Some studies accept a partner’s vasectomy if it was confirmed successful and that person is the participant’s only sexual partner.
Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
FT25625 and Non-Tobacco Non-Menthol SKU (FT254421)
Other: FT254421 · Other: FT25625
FT25629 and Tobacco SKU (FT25631)
Other: FT25631 · Other: FT25629
FT25629 and NTNM SKU (FT254421)
Other: FT254421 · Other: FT25629
FT25628 and NTNM SKU (FT254421)
Other: FT254421 · Other: FT25628
Non-Tobacco Non-Mint/Menthol SKU
Tobacco SKU
Device Two
Device Four
Device Four (fixed)
To descriptively characterize the user puffing topography measures (Session and Puff characteristics) of primary CC smokers when using one of two Vuse Pro Power Units and one of two e-liquid cartridges with the same nicotine concentration.
Time frame: 14 days
Evaluate Participant Demographics
Time frame: 14 days
Frequency of Use of Different Power Settings
To descriptively evaluate the frequency of use of different Vuse Pro Power Unit power settings throughout the 14-day study period.
Time frame: 14 days
Characterization of Device Mishandling and Misuse
Survey questionnaire at end of study.
Time frame: 14 days
Characterize use of other commercially available Vuse Pro Products
Through survey questionnaire.
Time frame: 14 days
Cigarette Consumption and use of other TNPs
Time frame: 14 days
Product Liking
Through survey questionnaire.
Time frame: 14 days
Purchase Intent of Study IP
Through survey questionnaire.
Time frame: 14 days
Plan to share: No
No publications or documents are linked to this record.
Started Oct 2026 (actual). Primary completion is estimated for Jan 2027, 3 months after the start.
Of 55 industry-sponsored interventional studies with no phase under Smoking, half reached primary completion within 3 months of starting (the median), counting those still running; a quarter within 1 and three quarters within 6. This study's planned 3 months is close to that.
Counting every sponsor, half of 457 studies reached it within 23 months; a quarter within 8 and three quarters within 40.
How these figures are worked out, and which studies are left out of them.
From the registry record's own update history. This site started tracking changes on Sep 25, 2026; for anything earlier, see the record history on ClinicalTrials.gov ↗
Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.
Contact study teamGet an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.